CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,000 | 0.0% | 197 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | -28.6% | 197 | -25.7% | 0.00% | – |
| Q4 2017 | $7,000 | +600.0% | 265 | +86.6% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 142 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | -98.1% | 142 | -98.1% | 0.00% | -100.0% |
| Q1 2016 | $103,000 | -28.0% | 7,532 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $143,000 | -3.4% | 7,532 | -4.7% | 0.00% | 0.0% |
| Q3 2015 | $148,000 | +1245.5% | 7,905 | +1013.4% | 0.00% | – |
| Q2 2015 | $11,000 | – | 710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,255,168 | $42,330,000 | 8.55% |
| SENZAR ASSET MANAGEMENT, LLC | 1,645,673 | $30,889,282,000 | 4.49% |
| Spark Investment Management LLC | 306,300 | $5,743,000 | 0.75% |
| TFS CAPITAL LLC | 382,196 | $7,174,000 | 0.69% |
| Granite Point Capital Management, L.P. | 47,097 | $884,000 | 0.61% |
| SPHERA FUNDS MANAGEMENT LTD. | 200,000 | $3,754,000 | 0.48% |
| EAM Investors, LLC | 134,121 | $2,517,000 | 0.40% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 236,517 | $4,439,000 | 0.32% |
| King Wealth Management Group | 25,980 | $488,000 | 0.30% |
| J. Goldman & Co LP | 74,000 | $1,388,000 | 0.12% |